NCT00619346View on ClinicalTrials.gov

Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Healthy
Interventions
DRUG

Placebo

Placebo tablets, BID X 14 days

DRUG

pafuramidine maleate

Pafuramidine maleate, 100 mg tablet BID X 14 days

Trial Locations (1)

9324

Farmovs-Parexel, Bloemfontein

Sponsors
All Listed Sponsors
lead

Immtech Pharmaceuticals, Inc

INDUSTRY